Ozempic Face Pushes Gen X Toward Facelifts Early
Gen X is turning to facelifts as GLP-1 weight-loss drugs reshape faces, pushing middle-aged adults to consider surgic...
Understanding when index funds are worth it depends on time horizon and fees. This quick guide outlines key scenarios and considerations.
14,133 articlesGen X is turning to facelifts as GLP-1 weight-loss drugs reshape faces, pushing middle-aged adults to consider surgic...
MacKenzie Scott’s philanthropy dominated megagifts in 2025, representing roughly one-third of the year’s total. New d...
Bitcoin’s rally back above $60,000 reversed sharply after June 25 inflation data, triggering a wave of long liquidati...
A TD Cowen analyst floated SpaceX purchasing T-Mobile, turning heads in investing circles as markets weigh strategic ...
A record-sized end-of-quarter options expiry is set to roll across Bitcoin and Ethereum, potentially stirring markets...
A new credit framework aims to turn crypto lending into a Wall Street–style, on-chain process to win back institutions.
Tech weakness and memory-chip swings are weighing on major indexes this June. Learn what’s driving the move and how t...
Tensions flare in the Persian Gulf as tit-for-tat attacks continue across the region despite a tentative U.S.-Iran ce...
Pipelines may not grab headlines, but their steady cash flow powers dividends for investors who plan ahead. Learn how...
Dividend income is quietly reshaping retirement budgets by funding housekeeping and other chores. This report explain...
Applied Materials just ripped higher again, sparking a profit-taking debate as the stock taps fresh highs. This repor...
At midyear 2026, JPMorgan’s top three overweight picks show a split: one stock has cleared its upside target, while t...